The Clorox Company (NYSE:CLX) Position Boosted by O Shaughnessy Asset Management LLC

O Shaughnessy Asset Management LLC lifted its stake in The Clorox Company (NYSE:CLX) by 10.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,829 shares of the company’s stock after purchasing an additional 1,980 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Clorox were worth $3,189,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in CLX. CIBC Private Wealth Group LLC boosted its stake in shares of Clorox by 0.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after buying an additional 66 shares during the period. Lindbrook Capital LLC boosted its position in Clorox by 6.2% during the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock valued at $181,000 after purchasing an additional 69 shares during the last quarter. Global Retirement Partners LLC grew its stake in Clorox by 7.2% in the fourth quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock valued at $156,000 after purchasing an additional 73 shares in the last quarter. West Branch Capital LLC increased its position in Clorox by 9.3% in the 4th quarter. West Branch Capital LLC now owns 903 shares of the company’s stock worth $129,000 after purchasing an additional 77 shares during the last quarter. Finally, Blue Trust Inc. raised its stake in shares of Clorox by 12.4% during the 4th quarter. Blue Trust Inc. now owns 698 shares of the company’s stock worth $91,000 after purchasing an additional 77 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Wells Fargo & Company lowered their price target on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. Citigroup decreased their target price on shares of Clorox from $150.00 to $145.00 and set a “neutral” rating for the company in a research report on Wednesday, July 10th. BNP Paribas began coverage on shares of Clorox in a report on Monday, June 24th. They set an “underperform” rating and a $130.00 price target on the stock. UBS Group decreased their price objective on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Finally, JPMorgan Chase & Co. cut their target price on Clorox from $158.00 to $150.00 and set a “neutral” rating on the stock in a report on Monday. Six equities research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $142.13.

Clorox Stock Performance

CLX stock traded up $0.24 on Wednesday, reaching $132.80. 767,175 shares of the company were exchanged, compared to its average volume of 1,232,006. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.14. The stock’s fifty day moving average price is $133.91 and its 200 day moving average price is $142.84. The firm has a market capitalization of $16.49 billion, a PE ratio of 68.81, a PEG ratio of 1.97 and a beta of 0.39.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The company had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the previous year, the firm posted $1.51 EPS. The business’s revenue was down 5.3% compared to the same quarter last year. On average, research analysts anticipate that The Clorox Company will post 5.92 EPS for the current fiscal year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.